371 related articles for article (PubMed ID: 19936768)
1. Protein tyrosine phosphatases in glioma biology.
Navis AC; van den Eijnden M; Schepens JT; Hooft van Huijsduijnen R; Wesseling P; Hendriks WJ
Acta Neuropathol; 2010 Feb; 119(2):157-75. PubMed ID: 19936768
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
[TBL] [Abstract][Full Text] [Related]
3. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
4. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
[TBL] [Abstract][Full Text] [Related]
6. Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights.
Bhavana ; Kohal R; Kumari P; Das Gupta G; Kumar Verma S
Bioorg Chem; 2024 Mar; 144():107121. PubMed ID: 38237392
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D; Gallagher W; Bennett DC
Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
[TBL] [Abstract][Full Text] [Related]
8. The Extended Family of Protein Tyrosine Phosphatases.
Alonso A; Nunes-Xavier CE; Bayón Y; Pulido R
Methods Mol Biol; 2016; 1447():1-23. PubMed ID: 27514797
[TBL] [Abstract][Full Text] [Related]
9. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatases as potential therapeutic targets.
He RJ; Yu ZH; Zhang RY; Zhang ZY
Acta Pharmacol Sin; 2014 Oct; 35(10):1227-46. PubMed ID: 25220640
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatases in development.
den Hertog J
Mech Dev; 1999 Jul; 85(1-2):3-14. PubMed ID: 10415342
[TBL] [Abstract][Full Text] [Related]
13. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B.
Meng TC; Buckley DA; Galic S; Tiganis T; Tonks NK
J Biol Chem; 2004 Sep; 279(36):37716-25. PubMed ID: 15192089
[TBL] [Abstract][Full Text] [Related]
14. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells.
Boivin B; Zhang S; Arbiser JL; Zhang ZY; Tonks NK
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9959-64. PubMed ID: 18632564
[TBL] [Abstract][Full Text] [Related]
15. A role for receptor tyrosine phosphatase zeta in glioma cell migration.
Müller S; Kunkel P; Lamszus K; Ulbricht U; Lorente GA; Nelson AM; von Schack D; Chin DJ; Lohr SC; Westphal M; Melcher T
Oncogene; 2003 Oct; 22(43):6661-8. PubMed ID: 14555979
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
[TBL] [Abstract][Full Text] [Related]
17. Expression of protein tyrosine phosphatases and Bombyx embryonic development.
Gu SH; Chen CH; Lin PL
J Insect Physiol; 2021 Apr; 130():104198. PubMed ID: 33549567
[TBL] [Abstract][Full Text] [Related]
18. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
[TBL] [Abstract][Full Text] [Related]
19. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor.
Pasquali C; Curchod ML; Wälchli S; Espanel X; Guerrier M; Arigoni F; Strous G; Hooft van Huijsduijnen R
Mol Endocrinol; 2003 Nov; 17(11):2228-39. PubMed ID: 12907755
[TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
